General Information of Drug (ID: DM83HUI)

Drug Name
Gamma-thiobutyrolactone Drug Info
Synonyms
Dihydro-2(3H)-thiophenone; Dihydro-2-(3H)-thiophenone; KMSNYNIWEORQDJ-UHFFFAOYSA-N; Tetrahydro-2-thiophenone; Thiacyclopentan-2-one; Thiacyclopentanone-2; Thiolan-2-one; dihydrothiophen-2(3H)-one; gamma-Thiobutyrolactone; thiolanone; .gamma.-Thiobutyrolactone; 1003-10-7; 2(3H)-Thiophenone, dihydro-; 2-Oxothiolane; 2-THIOPHENONE, TETRAHYDRO-; 2-Thiolanone; 2-oxotetrahydrothiophene; 4-Butyrothiolactone; 4-Thiobutyrolactone; A3ERZ734SN; AC1L22MB; BRN 0105273; CHEBI:89059; EINECS 213-700-8; NSC 54087; SCHEMBL13480; UNII-A3ERZ734SN
Cross-matching ID
PubChem CID
13852
ChEBI ID
CHEBI:89059
CAS Number
CAS 1003-10-7
TTD Drug ID
DM83HUI
INTEDE Drug ID
DR2014

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DME
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Loteprednol Etabonate DM8QTJI Eye inflammation 9A02 Approved [2]
Prulifloxacin DMOK965 Urinary tract infection GC08 Approved [3]
RTR-003632 DM45NHF N. A. N. A. Phase 2 [1]
PARAOXON DMN4ZKC Discovery agent N.A. Investigative [1]
gamma-butyrolactone DMDCZWY Discovery agent N.A. Investigative [1]
Coumaranone DM7TCPG N. A. N. A. Investigative [1]
Dihydrocoumarin DMGLX1R N. A. N. A. Investigative [1]
Homogentisic acid DMQD0YW N. A. N. A. Investigative [1]
⏷ Show the Full List of 8 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug-Metabolizing Enzyme (DME)
DME Name DME ID UniProt ID MOA REF
Serum paraoxonase/arylesterase 1 (PON1) Main DME DESDN74 PON1_HUMAN Substrate [1]

References

1 Human serum paraoxonase (PON1) isozymes Q and R hydrolyze lactones and cyclic carbonate esters. Drug Metab Dispos. 2000 Nov;28(11):1335-42.
2 Identification of esterase involved in the metabolism of two corticosteroid soft drugs. Biochem Pharmacol. 2017 Mar 1;127:82-89.
3 Paraoxonases-1, -2 and -3: what are their functions? Chem Biol Interact. 2016 Nov 25;259(Pt B):51-62.